Yvoire Volume Plus — HICE HA Filler for Deep Wrinkles & Facial Volumising

Yvoire Volume Plus is LG Chem’s mid-deep variant — 20 mg/mL cross-linked HA + 0.3% lidocaine via patented HICE technology with 3 million Dalton high-molecular-weight HA. Engineered for deep dermal and subcutaneous placement targeting deep wrinkles, cheek augmentation, forehead volumising, nasolabial folds, and significant lip augmentation. 9-12 months durability.

Yvoire Volume Plus HA Filler with Lidocaine is manufactured by LG Chem, a South Korea-based medical device and pharmaceutical company established in 2010. The product is part of the Yvoire dermal filler range, which is distributed across multiple international markets. Regulatory status: FDA DMF #17416 · EDQM certified · KFDA · CE marked.

Yvoire Volume Plus HA Filler with Lidocaine contains 20 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using LG Chem’s HICE (High Concentration Equalized) Cross-Linking Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.

Per LG Chem’s clinical data, Yvoire Volume Plus HA Filler with Lidocaine delivers 9-12 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Deep dermis placement typically delivers the longer end of the duration range.

Yvoire Volume Plus HA Filler with Lidocaine is engineered for deep dermis · subcutaneous placement. The standard recommended needle is 27G, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.

Yvoire Volume Plus HA Filler with Lidocaine regulatory status: FDA DMF #17416 · EDQM certified · KFDA · CE marked. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.

Store Yvoire Volume Plus HA Filler with Lidocaine between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.

No. Yvoire Volume Plus HA Filler with Lidocaine uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).

Yes — layered protocols combining different fillers are standard aesthetic practice. Yvoire Volume Plus HA Filler with Lidocaine can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.

Both are deep-placement HA fillers for cheek augmentation but with different profiles. Yvoire Volume Plus uses LG Chem’s HICE technology with 20 mg/mL HA + 0.3% lidocaine and FDA DMF registration. Juvederm Voluma uses Allergan’s Vycross technology (VYC-20L) with 20 mg/mL HA + 0.3% lidocaine and direct FDA approval for cheek augmentation. Voluma typically delivers longer durability (up to 18 months) due to Vycross’s low-MW HA component. Yvoire Volume Plus delivers 9-12 months but at significantly lower per-syringe cost — supporting different practice positioning strategies.